BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,301 Cr | ₹1,212 Cr | ₹1,154 Cr | ₹1,109 Cr | ₹1,077 Cr |
What is the latest Total Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,301 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹1,154 Cr |
| Mar2022 | ₹1,109 Cr |
| Mar2021 | ₹1,077 Cr |
How is Total Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,301 Cr | 7.37 | |
| Mar2024 | ₹1,212 Cr | 5.03 | |
| Mar2023 | ₹1,154 Cr | 4.04 | |
| Mar2022 | ₹1,109 Cr | 2.97 | |
| Mar2021 | ₹1,077 Cr | - | |
Compare Total Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,849.2 Cr | 5.8% | 40.4% | 109.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 5.8% |
40.4% |
109.9% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses